NYU Technology Opportunities & Ventures

It was a great turnout for yesterday's Industry Insights on Research and Innovation Seminar, part of a series where we hear from startups turning cutting-edge science into impactful solutions. A huge thank you Dr. Kathryn Moore (NYULH Cardiology) and Dr. Alisha (Jonesy) Jones (New York University Chemistry) who showcased their project Targeting the Primate-Specific lncRNA CHROMR in Type I Interferonopathies, and Dr. Richard Possemato (NYULH Pathology) who showcased his project Identifying Inhibitors of DNA Polymerase Epsilon (POLE) to Treat Triple Negative Breast Cancer. Both translational programs are being developed under the auspices of Therapeutics Alliances (TA), TOV's life science accelerator program. #NYU_IIRIS #TherapeuticsAlliances

A new study from NYU Langone Health, led by Dr. Shohei Koide, highlights the feasibility of developing novel therapeutics for cancers that are mediated by oncogenic mutations in the NRAS gene, such as colon cancer, melanoma, leukemia, and myeloma.   Building upon their previous studies with monobodies that recognize other HRAS and KRAS gene mutations associated with cancer, these findings report the development of a monobody that inhibits oncogenic NRAS-mediated signaling in all variations of gene mutation and does not inhibit the essential cellular functions of the KRAS and HRAS genes.   📖 Read the study: https://lnkd.in/etkaujka   🤝 NYU TOV is looking for a partner to help commercialize this promising cancer therapeutic! To learn more about the innovation and how to partner with us visit ➡ https://lnkd.in/eEJa_Wbw, or contact business development manager Douglas Brawley, PhD or licensing associate Keaton Crosse, PhD. #oncogenicmutations #NRAS #CancerTreatment #DrugDiscovery #CancerTherapeutic #monobody #coloncancer #melanoma #leukemia #myeloma

A huge thank you to TOV's executive director of technology transfer Abram Goldfinger, who spoke to the Biomedical Entrepreneurship Course class yesterday about licensing and how to work with the technology transfer office! #NYUInnovation

📢 NYU community - Join us next Thursday, October 17 at noon for our next Industry Insights on Research and Innovation Seminar, part of a series where we hear from startups turning cutting-edge science into impactful solutions. We're doing something special for October’s seminar, showcasing two NYU Langone Health translational programs being developed under the auspices of Therapeutics Alliances (TA), TOV's life science accelerator program. Program 1️⃣: Targeting the Primate-Specific lncRNA CHROMR in Type I Interferonopathies Presented by innovators Dr. Kathryn Moore (NYULH Cardiology) and Dr. Alisha (Jonesy) Jones (New York University Chemistry) Program 2️⃣: Identifying Inhibitors of DNA Polymerase Epsilon (POLE) to Treat Triple Negative Breast Cancer Presented by innovator Dr. Richard Possemato (NYULH Pathology) Learn more and register here ➡ https://lnkd.in/ev35gnf7 #NYUInnovation #NYUResearch #TherapeuticsAlliances #research #innovation #science #drugdiscovery #development #startups

🎉 Join us in celebrating Elizabeth Sheckler, Ph.D., RTTP, our licensing and business development manager for digital and creative works, on her new certification as a Registered Technology Transfer Professional from the ATTP (The Alliance of Technology Transfer Professionals)!! Way to go, Beth!

NYU startup founders Srushti Katore of CARA Systems Inc. and Lokesh Sharma of CaroRhythm sat on a panel today during the NYU Entrepreneurs Festival at NYU Stern School of Business, and shared their experience starting a company while in school. The event was hosted by the NYU Entrepreneurial Institute and the Berkley Center for Entrepreneurship .

📢 NYU community - There's still time to register for our upcoming 4-part webinar series: Intellectual Property for NYU Innovators to learn how innovations are protected at NYU. October 9th, October 16th, October 25th, October 30th, 9:30 - 10:30 AM ET. Register here ➡ https://lnkd.in/e6DC2XDc Presenters will include Drs. Shilpa V. Patel, PhD, JD, and Sadhana Chitale, PhD, MBA from TOV along with attorneys from the law firm, Troutman Pepper. Topics will include: ✔ Types of intellectual property ✔ Patent and copyright procurement processes ✔ Subject matter eligible for patent and copyright protection ✔ Inventorship ✔ Commercialization at NYU ✔ Recent trends in AI This series is free and open to the NYU and NYU Langone Health community, but registration is required.

So excited to share that New York University has been named a top 10 Ignition School by Fast Company and Inc. Magazines. #IgnitionSchools "honors the top academic institutions that play an enormous role in shaping the businesses that influence society." To be cited among those that "...don’t just produce elite students and groundbreaking research; they also are economic engines that generate the ideas, businesses, and opportunities that move cities, regions, and countries toward a better future" is quite an honor. This is truly a reflection and honor bestowed upon the 60,000+ students, 5,000+ faculty and countless staff and administrators that make NYU the hub of entrepreneurship, innovation and research commercialization that it is today! Special shoutout to the teams at the NYU Entrepreneurial Institute, NYU Technology Opportunities & Ventures, Berkley Center for Entrepreneurship , NYU Tandon Future Labs, NYU MakerSpace and other centers and hubs that have the privilege of supporting our students and faculty in their entrepreneurial and innovation endeavors every day! Moreover, we couldn't do this without the countless donors, sponsors, mentors, investors, speakers and others that contribute to supporting NYU founders. Thank you! It's a cliche, but it takes a village, and we are very fortunate to have an amazing one! Watch this space. We're just getting started! Read more at https://lnkd.in/eJ3j6cBQ

It was another great class in our Biomedical Entrepreneurship Course last night. A big thanks to TOV’s director of IP Dr. Shilpa V. Patel who spoke to the class about IP protection. #NYUInnovation

It was a great kickoff yesterday to this year's Industry Insights on Research and Innovation Seminar (IIRIS) Series, where we hear from startups turning cutting-edge science into impactful solutions. A huge thank you to our guest speaker Dr. Archis Bagati, founder and CEO of Pyrojas, which is developing immunotherapies that harness the power of the immune system to recognize and destroy cancer cells. #NYU_IIRIS #NYUInnovation